NCT05201092View on ClinicalTrials.gov

A Study Investigating Lu AG06466 in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

February 19, 2022

Study Completion Date

February 19, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-Lu AG06466

\[14C\]-Lu AG06466 will be administered per schedule specified in the arm description.

Trial Locations (1)

LS2 9LH

LabCorp Clinical Research Unit Ltd, Leeds

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT05201092 - A Study Investigating Lu AG06466 in Healthy Men | Biotech Hunter | Biotech Hunter